Related Experiment Videos
Heparin inhalation for asthma
1Faculté de Pharmacie, Université de Montréal, Canada.
The Annals of Pharmacotherapy
|January 1, 1995
Summary
Inhaled heparin shows potential anti-inflammatory effects for asthma, but current research is preliminary. Further trials are needed to determine its optimal use and safety in asthma management.
Area of Science:
- Pulmonology
- Pharmacology
Background:
- Asthma pathogenesis is increasingly understood.
- Inhaled heparin is being re-evaluated for asthma treatment.
Purpose of the Study:
- To assess the current evidence for inhaled heparin in asthma.
- To identify key areas for future research in inhaled heparin therapy for asthma.
Main Methods:
- Review of recent medical literature on inhaled heparin in asthma.
- Identification of preliminary findings and limitations.
Main Results:
- Current data on inhaled heparin for asthma is scant and preliminary.
- Inhaled heparin may offer anti-inflammatory benefits without steroid-like adverse effects.
Conclusions:
- Inhaled heparin is not yet recommended for acute or chronic asthma.
- Further well-designed human trials are essential to define its role in asthma therapy and prevention, addressing optimal dosage, patient subpopulations, timing, delivery, and long-term safety.